SB61

Summary

A South Dakota bill that would have banned non-medical hemp-derived intoxicants failed in committee by a vote of 14–19 and has been placed on the calendar under the failed measures process. The bill's failure leaves the hemp-derived intoxicant market intact in South Dakota, meaning retailers and manufacturers currently selling those products face no immediate prohibition.

More South Dakota Cannabis Bills

• HB1099Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.Passed
• HB1160Repeal the medical marijuana oversight committee.In Committee
• HB1255Require that the Department of Health accept the medical records of a veteran applying for a medical cannabis registry identification card.Introduced
• HB1211Create a digital registry identification card for medical cannabis patients.Introduced
• SB143Require that the Department of Health annually report on public health effects of cannabis use.Introduced
• SB95Require that a medical cannabis cardholder provide a card or card number upon request of a law enforcement officer.Introduced
• HB1053Require that terminal care facilities allow terminally ill patients to use medical cannabis.Introduced